antiquity
11-13-2001, 06:54 AM
Effective Treatment for Neuropathic Pain
Nov. 13, 2001 (Ivanhoe Newswire) - Patients suffering from neuropathic pain may benefit from a drug that may provide greater relief and fewer side effects than traditional treatments.
Researchers from the University of Arizona in Tucson tested the antidepressant bupropion SR (sustained-release) for the treatment of neuropathic pain. Neuropathic pain is caused by a disturbance of the peripheral or central nervous system and leads to symptoms of shooting and burning sensations, numbness and tingling. While tricyclic antidepressants are the common form of treatment for neuropathic pain, many patients stop taking these drugs because they are either not effective or produce intolerable side effects.
More than 40 patients with neuropathic pain were enrolled in the study. Researchers found 73 percent, or about 30 patients, reported improved or much improved pain after 6 weeks of taking a daily dose of bupropion SR. They add 90 percent of patients say their pain was worse or unchanged while taking placebo.
Many experts believe when depressed patients who also suffer from neuropathic pain are given antidepressants; their pain is often reduced. Researches believe the effect of the drug may be due to alleviating the depression, not the cause of the pain itself. However, researchers in the current study enrolled only non-depressed patients and still found a beneficial effect. Marilyn Semenchuk, Pharm.D., from the University of Arizona, is quoted as saying, "By using non-depressed patients, the previous argument doesn't hold."
SOURCE: Neurology, 2001;57:1583-1588
Nov. 13, 2001 (Ivanhoe Newswire) - Patients suffering from neuropathic pain may benefit from a drug that may provide greater relief and fewer side effects than traditional treatments.
Researchers from the University of Arizona in Tucson tested the antidepressant bupropion SR (sustained-release) for the treatment of neuropathic pain. Neuropathic pain is caused by a disturbance of the peripheral or central nervous system and leads to symptoms of shooting and burning sensations, numbness and tingling. While tricyclic antidepressants are the common form of treatment for neuropathic pain, many patients stop taking these drugs because they are either not effective or produce intolerable side effects.
More than 40 patients with neuropathic pain were enrolled in the study. Researchers found 73 percent, or about 30 patients, reported improved or much improved pain after 6 weeks of taking a daily dose of bupropion SR. They add 90 percent of patients say their pain was worse or unchanged while taking placebo.
Many experts believe when depressed patients who also suffer from neuropathic pain are given antidepressants; their pain is often reduced. Researches believe the effect of the drug may be due to alleviating the depression, not the cause of the pain itself. However, researchers in the current study enrolled only non-depressed patients and still found a beneficial effect. Marilyn Semenchuk, Pharm.D., from the University of Arizona, is quoted as saying, "By using non-depressed patients, the previous argument doesn't hold."
SOURCE: Neurology, 2001;57:1583-1588